The Effect of Glucagon-Like Peptide-1 Receptor Agonist Therapy on Body Mass Index in Adolescents with Severe Obesity: A Randomized, Placebo-Controlled, Clinical Trial

OBJECTIVE: To evaluate the effects of exenatide on body mass index (BMI) and cardiometabolic risk factors in adolescents with severe obesity. DESIGN: Three-month, randomized, double-blind, placebo-controlled, multicenter clinical trial followed by a three-month open label extension. SETTING: An acad...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Kelly, Aaron S., Rudser, Kyle D., Nathan, Brandon M., Fox, Claudia K., Metzig, Andrea M., Coombes, Brandon J., Fitch, Angela K., Bomberg, Eric M., Abuzzahab, M. Jennifer
Formato: Artigo
Idioma:Inglês
Publicado em: 2013
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4010226/
https://ncbi.nlm.nih.gov/pubmed/23380890
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamapediatrics.2013.1045
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados